Empire Life Investments’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-941,249
Closed -$4.56M 110
2020
Q1
$4.56M Buy
941,249
+369,026
+64% +$1.79M 0.42% 54
2019
Q4
$6.08M Buy
572,223
+57,954
+11% +$616K 0.46% 50
2019
Q3
$5.35M Buy
514,269
+177,645
+53% +$1.85M 0.45% 53
2019
Q2
$5.16M Sell
336,624
-36,562
-10% -$560K 0.42% 65
2019
Q1
$4.8M Sell
373,186
-677
-0.2% -$8.7K 0.4% 66
2018
Q4
$3.55M Buy
373,863
+274,742
+277% +$2.61M 0.32% 68
2018
Q3
$1.65M Buy
99,121
+65,357
+194% +$1.08M 0.13% 81
2018
Q2
$542K Buy
33,764
+151
+0.4% +$2.42K 0.04% 87
2018
Q1
$514K Hold
33,613
0.04% 91
2017
Q4
$524K Hold
33,613
0.04% 85
2017
Q3
$373K Buy
+33,613
New +$373K 0.03% 98